Presentation AHA 2016 Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure (EFFECT-HF) Presenter: Dirk J. van Veldhuisen November 16, 2016
Presentation TCT 2016 Prognostic and Treatment Decision Implications of Exercise Induced Mitral Regurgitation Presenter: Paul A. Grayburn, Patrizio Lancellotti October 30, 2016
Presentation TCT 2015 Exercise-Induced MR: Prognosis and Practicality Presenter: Robert J. Siegel, Neil J. Weissman, Luc A Pierard October 11, 2015
Presentation Effect of Baseline Exercise Capacity on Outcomes in Patients With Stable Coronary Heart Disease Presenter: S.K. Padala September 08, 2015
Presentation Supervised Exercise, Stent Revascularization, or Medical Therapy for Claudication Due to Aortoiliac PAD Presenter: Timothy P. Murphy March 09, 2015
Presentation Effect on Outcomes and Exercise Performance of Anemia in TAVR Patients Presenter: H. DeLarochelli?re December 08, 2014
Presentation TCT 2014 Role of Exercise and Viability in the Evaluation of Mitral Regurgitation Presenter: Paul A. Grayburn, Robert J. Siegel, Scott Lim, Maurice E. Sarano September 13, 2014
Presentation TCT 2013 PCI vs. Medical Therapy to Improve Exercise Capacity and Relieve Angina in SIHD: Prior Studies and Rationale for a New Randomized Trial Presenter: Justin Davies October 29, 2013
Presentation TCT 2012 “Asymptomatic” Severe Aortic Stenosis: Use of Exercise Testing, Watchful Waiting vs. Early Valve Replacement Presenter: Blase Carabello October 22, 2012
Presentation Exercise Testing in Asymptomatic Patients After Revascularization Presenter: S. C. Harb May 23, 2012
Presentation Provoked Exercise Desaturation in Patent Foramen Ovale and Impact of Percutaneous Closure Presenter: G.P. Devendra April 19, 2012
Presentation CTO 2012 Noninvasive Imaging for Assessment of Left Main Severity: From Exercise Performance to Nuclear Techniques to CT and MRI Presenter: James Min February 22, 2012